Shareholders who lost money in shares of Nutex Health Inc. (NASDAQ: NUTX) Should Contact Wolf Haldenstein Immediately

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for allegedly making false and misleading statements regarding its business and financial conditions [1][2]. Allegations - Nutex and its executives are accused of failing to disclose material facts about the company's business and finances [2]. - The lawsuit claims that Nutex benefited from arbitration results secured by HaloMD, which is alleged to have engaged in fraudulent schemes to defraud insurance companies [6]. - It is alleged that Nutex reported unsustainable revenues tied to this alleged fraud [6]. - The company is accused of overstating its remediation of internal control weaknesses over financial reporting [6]. - Nutex allegedly failed to properly account for stock-based compensation obligations, misclassifying them as equity instead of liabilities [6]. - The lawsuit highlights an increased risk of delayed SEC filings due to these accounting errors [6]. - Nutex is accused of overstating its business and financial prospects through misleading positive statements [6]. Key Events - On July 22, 2025, a report from Blue Orca Capital alleged that Nutex used HaloMD in fraudulent arbitration schemes, resulting in a stock price drop of $11.18 (10.1%), closing at $100.01 [6]. - On August 14, 2025, Nutex announced a delay in its Q2 2025 financial filings due to accounting issues related to stock-based compensation, leading to a further stock price decline of $18.22 (16.4%), closing at $92.91 on August 15 [6]. Class Period and Deadlines - The class period for the lawsuit is from August 8, 2024, to August 14, 2025 [6]. - The deadline to file a lead plaintiff motion is October 21, 2025 [6].